Navigation Links
FDA Approves INTUNIV® (guanfacine) Extended-Release Tablets for Use as Adjunctive Therapy to Stimulants for the Treatment of ADHD in Children and Adolescents
Date:2/28/2011

10th revision (ICD-10).(3,4)

Although there is no cure for ADHD, there are accepted treatments that have been demonstrated to improve symptoms.(4)  Standard treatments include educational approaches, psychological therapies that may include behavioral modification, and/or medication.(4)

Notes to editors

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, the Company's results could be materially adversely affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of research, development, approval, reimbursement, manufacturing and commercialization of the Company's Specialty Pharmaceutical and Human Genetic Therapies products, as well as the ability to secure and integrate new products
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Edarbi to Treat High Blood Pressure
2. FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
3. FDA Approves Product to Prevent Bleeding in People With Rare Genetic Defect
4. FDA Approves First 3-D Mammography Imaging System
5. FDA Approves 1st Pacemaker Designed to Work Safely During Some MRI Exams
6. FDA Approves Hologics Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
7. FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women
8. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
9. FDA Approves Viibryd to Treat Major Depressive Disorder
10. FDA Approves Head Lice Treatment for Children and Adults
11. FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014  Conkwest, Inc., the Natural Killer Cell ... Killer (NK) cell-line platform, Neukoplast® (NK-92™) as an ... , NantWorks founder, physician scientist and biotechnology entrepreneur, ... approximately $48 million of the Company,s Class A ... will be named Co-Chairman of the Conkwest Board ...
(Date:12/24/2014)... and LONDON , December ... orthopedic industry are expected to grow at an average ... terms of value and volume. Hip, knee and spine ... world while in emerging economies they have a lower ... are challenging the use of composites. Non-metallic orthopedic devices ...
(Date:12/24/2014)... , Dec. 23, 2014  Advanced Medical Isotope ... engaged primarily in the development of brachytherapy devices ... today announced that it has filed a ... Drug Administration ("FDA") for marketing clearance for its ... of the U.S. Food, Drug and Cosmetic Act ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 2Advanced Medical Isotope Corporation Files a "de novo" Submission for Y-90 RadioGel(TM) Device 3
... 2007- Biota Holdings,Limited (ASX:BTA) today announced that ... anti-influenza,treatment, has: , ,1. demonstrated effectiveness against ... I studies in Japan; and ,3. received ... the,UK. , ,Biota’s partner for LANI, Daiichi-Sankyo, ...
... GENEVA, April 20, 2007 /PRNewswire/ -- Addex Pharmaceuticals,announced ... proof of,concept trial with its lead compound ADX10059 ... objective, the absence of,pain at 2 hours after ... improvement in pain-free status and,improvement of migraine pain ...
Cached Medicine Technology:LANI completes Phase I in Japan and to commence Phase I in UK 2LANI completes Phase I in Japan and to commence Phase I in UK 3LANI completes Phase I in Japan and to commence Phase I in UK 4Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 2Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 3Addex Reports Positive Results in Phase IIa Clinical Trial With,ADX10059 in Migraine 4
(Date:12/26/2014)... 26, 2014 India Network Foundation, a ... the USA, announced today a new version of “ ... choosing the right plan for their visiting parents. The ... of the selection process when choosing an insurance plan ... with only a few clicks. Many elderly Asian Indian ...
(Date:12/26/2014)... Parker & Sons, Inc. a ... heating, cooling and plumbing contractor services throughout Arizona ... in 2014 with regard to air-conditioning systems. Residential ... known for its incredibly hot summers. Working with ... and details of a wide variety of systems ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... Product liability lawsuits filed in the ... http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal court, ... in the U.S. District Court, Northern District of Ohio ... conference on January 7, 2015, at the Paul G. ... Palm Beach, Florida. The Conference is scheduled to begin ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online ... its collection of discounted prom dresses, most of which ... spokesman of the company, the promotion is valid until ... to expand the UK market. , The prom dresses ... lengths, and styles: A-line strapless, empire strapless chiffon, one ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... says , , HOUSTON, June 5 Noted Houston trial lawyer ... Firm says "useless trick science" is the basis for a ... (NYSE: GSK ) about the side effects caused by the ... linked to heart problems in thousands of patients. , , Mr. ...
... Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense ... the 8th Annual Needham Life Sciences Conference on Thursday, June 11, ... , , A live audio webcast of the ... Company,s Web site, www.isispharm.com . A replay ...
... ... System (VHS) announced today they have mutually decided to terminate their contractual relationship. Effective ... but will be retained to provide ongoing group purchasing and supply chain management services. ... Brentwood, Tenn. ...
... , ... has partnered with Piedmont Community College to offer training to individuals interested in pursing ... ... Career Step, a leading online healthcare education company, has partnered with Piedmont Community College ...
... ... its new website, bestpills.co.uk/- the new online pharmacology website, serving the privacy minded individual. ... London, England ... launching of their new, widely prescribed prescription drug website - bestpills.co.uk., , ,The site ...
... Steps They Would During Any Flu Outbreak , , HARRISBURG, ... 2009 Novel Influenza A/H1N1 was reported today in Berks County. Currently, ... illness due to this virus. Nationally, there are 11,054 confirmed cases ... of this 55-year-old woman is a sad reminder of the complications ...
Cached Medicine News:Health News:Avandia Attorney Says Study Based on 'Useless Trick Science' 2Health News:Avandia Attorney Says Study Based on 'Useless Trick Science' 3Health News:QHR and Valley Health Amicably Part Ways 2Health News:Career Step Partners with Piedmont Community College to Help Students Gain Careers in Growing Healthcare Industry 2Health News:Bestpills Launchs its New Online Pharmacy 2Health News:Health Department Reports Pennsylvania's First Death Due to 2009 Novel Influenza A/H1N1 Virus 2
... is a fully automated ... for clotting, photometric and ... tests.The medium-throughput analyser offers ... tubes, 45 reagents onboard, ...
... KeraCel Ophthalmic Products are constructed ... of lint-free MEROCEL polyvinyl acetal ... to be beneficial to both ... absorbent, and yet firm enough ...
... Haemolance safety lancets are ... to obtain capillary blood ... frequently used for monitoring ... may also be used ...
The Unistik 3 family of single use safety lancets has 4 models for use across all clinical environments....
Medicine Products: